vs
CAPRICOR THERAPEUTICS, INC.（CAPR）与Finward Bancorp（FNWD）财务数据对比。点击上方公司名可切换其他公司
Finward Bancorp的季度营收约是CAPRICOR THERAPEUTICS, INC.的1.5倍（$16.5M vs $11.1M），Finward Bancorp净利率更高（12.0% vs -63.9%，领先76.0%），Finward Bancorp同比增速更快（1.1% vs -7.9%），Finward Bancorp自由现金流更多（$9.0M vs $-15.3M），过去两年CAPRICOR THERAPEUTICS, INC.的营收复合增速更高（93.0% vs -19.1%）
Capricor Therapeutics是一家处于临床阶段的生物技术企业，专注于研发及商业化细胞疗法、基因疗法等创新生物制剂，覆盖罕见病、心血管疾病、肌肉疾病等领域，主要面向美国市场，致力为治疗选择有限的患者填补未被满足的医疗需求。
Finward Bancorp是一家总部位于美国的区域性银行控股公司，主要面向本土运营区域内的个人消费者与中小企业，提供储蓄账户、各类贷款、商业融资及财富管理等零售与商业金融服务。
CAPR vs FNWD — 直观对比
营收规模更大
FNWD
是对方的1.5倍
$11.1M
营收增速更快
FNWD
高出9.0%
-7.9%
净利率更高
FNWD
高出76.0%
-63.9%
自由现金流更多
FNWD
多$24.3M
$-15.3M
两年增速更快
CAPR
近两年复合增速
-19.1%
损益表 — Q4 FY2024 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $11.1M | $16.5M |
| 净利润 | $-7.1M | $2.0M |
| 毛利率 | — | — |
| 营业利润率 | -69.1% | 11.0% |
| 净利率 | -63.9% | 12.0% |
| 营收同比 | -7.9% | 1.1% |
| 净利润同比 | -833.8% | -5.6% |
| 每股收益（稀释后） | $-0.11 | $0.46 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CAPRFNWD
| Q4 25 | — | $16.5M | ||
| Q3 25 | — | $17.4M | ||
| Q2 25 | — | $16.6M | ||
| Q1 25 | — | $15.5M | ||
| Q4 24 | $11.1M | $16.3M | ||
| Q3 24 | $2.3M | $14.9M | ||
| Q2 24 | $4.0M | $14.6M | ||
| Q1 24 | $4.9M | $25.3M |
净利润CAPRFNWD
| Q4 25 | — | $2.0M | ||
| Q3 25 | — | $3.5M | ||
| Q2 25 | — | $2.2M | ||
| Q1 25 | — | $455.0K | ||
| Q4 24 | $-7.1M | $2.1M | ||
| Q3 24 | $-12.6M | $606.0K | ||
| Q2 24 | $-11.0M | $143.0K | ||
| Q1 24 | $-9.8M | $9.3M |
营业利润率CAPRFNWD
| Q4 25 | — | 11.0% | ||
| Q3 25 | — | 20.5% | ||
| Q2 25 | — | 12.7% | ||
| Q1 25 | — | 4.0% | ||
| Q4 24 | -69.1% | 16.3% | ||
| Q3 24 | -575.2% | 2.7% | ||
| Q2 24 | -291.9% | 0.9% | ||
| Q1 24 | -209.2% | 40.6% |
净利率CAPRFNWD
| Q4 25 | — | 12.0% | ||
| Q3 25 | — | 20.1% | ||
| Q2 25 | — | 12.9% | ||
| Q1 25 | — | 2.9% | ||
| Q4 24 | -63.9% | 12.9% | ||
| Q3 24 | -555.2% | 4.1% | ||
| Q2 24 | -277.0% | 1.0% | ||
| Q1 24 | -199.6% | 36.7% |
每股收益（稀释后）CAPRFNWD
| Q4 25 | — | $0.46 | ||
| Q3 25 | — | $0.81 | ||
| Q2 25 | — | $0.50 | ||
| Q1 25 | — | $0.11 | ||
| Q4 24 | $-0.11 | $0.50 | ||
| Q3 24 | $-0.38 | $0.14 | ||
| Q2 24 | $-0.35 | $0.03 | ||
| Q1 24 | $-0.31 | $2.17 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $151.5M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $145.5M | $174.7M |
| 总资产 | $170.5M | $2.0B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CAPRFNWD
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $151.5M | — | ||
| Q3 24 | $85.0M | — | ||
| Q2 24 | $29.5M | — | ||
| Q1 24 | $39.9M | — |
股东权益CAPRFNWD
| Q4 25 | — | $174.7M | ||
| Q3 25 | — | $165.5M | ||
| Q2 25 | — | $154.3M | ||
| Q1 25 | — | $151.8M | ||
| Q4 24 | $145.5M | $151.4M | ||
| Q3 24 | $68.3M | $159.6M | ||
| Q2 24 | $11.5M | $148.6M | ||
| Q1 24 | $18.4M | $151.6M |
总资产CAPRFNWD
| Q4 25 | — | $2.0B | ||
| Q3 25 | — | $2.1B | ||
| Q2 25 | — | $2.1B | ||
| Q1 25 | — | $2.0B | ||
| Q4 24 | $170.5M | $2.1B | ||
| Q3 24 | $93.0M | $2.1B | ||
| Q2 24 | $38.3M | $2.1B | ||
| Q1 24 | $49.4M | $2.1B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-14.8M | $9.9M |
| 自由现金流经营现金流 - 资本支出 | $-15.3M | $9.0M |
| 自由现金流率自由现金流/营收 | -137.3% | 54.8% |
| 资本支出强度资本支出/营收 | 4.4% | 5.2% |
| 现金转化率经营现金流/净利润 | — | 4.99× |
| 过去12个月自由现金流最近4个季度 | $-41.2M | $10.6M |
8季度趋势，按日历期对齐
经营现金流CAPRFNWD
| Q4 25 | — | $9.9M | ||
| Q3 25 | — | $1.2M | ||
| Q2 25 | — | $4.8M | ||
| Q1 25 | — | $-3.8M | ||
| Q4 24 | $-14.8M | $9.8M | ||
| Q3 24 | $-11.6M | $-3.7M | ||
| Q2 24 | $-12.3M | $2.8M | ||
| Q1 24 | $-1.3M | $-25.0K |
自由现金流CAPRFNWD
| Q4 25 | — | $9.0M | ||
| Q3 25 | — | $1.0M | ||
| Q2 25 | — | $4.5M | ||
| Q1 25 | — | $-4.0M | ||
| Q4 24 | $-15.3M | $6.7M | ||
| Q3 24 | $-11.7M | $-4.2M | ||
| Q2 24 | $-12.3M | $1.1M | ||
| Q1 24 | $-1.9M | $-736.0K |
自由现金流率CAPRFNWD
| Q4 25 | — | 54.8% | ||
| Q3 25 | — | 6.0% | ||
| Q2 25 | — | 27.0% | ||
| Q1 25 | — | -25.7% | ||
| Q4 24 | -137.3% | 41.2% | ||
| Q3 24 | -515.2% | -28.5% | ||
| Q2 24 | -310.9% | 7.6% | ||
| Q1 24 | -38.3% | -2.9% |
资本支出强度CAPRFNWD
| Q4 25 | — | 5.2% | ||
| Q3 25 | — | 0.9% | ||
| Q2 25 | — | 1.7% | ||
| Q1 25 | — | 1.2% | ||
| Q4 24 | 4.4% | 18.8% | ||
| Q3 24 | 0.4% | 3.4% | ||
| Q2 24 | 1.5% | 11.2% | ||
| Q1 24 | 12.4% | 2.8% |
现金转化率CAPRFNWD
| Q4 25 | — | 4.99× | ||
| Q3 25 | — | 0.34× | ||
| Q2 25 | — | 2.22× | ||
| Q1 25 | — | -8.37× | ||
| Q4 24 | — | 4.66× | ||
| Q3 24 | — | -6.15× | ||
| Q2 24 | — | 19.23× | ||
| Q1 24 | — | -0.00× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
